Our Mission

Trial Acceleration Institute collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times.

Assisting stakeholders with actionable resolutions to their specific cycle time challenges (from protocol feasibility to patient retention) via the identification and initiation of best-of-class, third-party solutions is the primary mission of Trial Acceleration Institute.

In our first two years of operation, the Institute has collaborated with more than 50 stakeholders spanning pharmaceutical companies, biotechnology companies, CROs, SMOs, investigators, patient recruitment service providers and niche informatics companies. We have focused on strategic interventions in the areas of protocol feasibility, investigator performance, patient recruitment and retention.

Clinical trial sponsors have engaged Trial Acceleration Institute to optimize traditional interventions as well as discover and evaluate emerging trial acceleration tactics. Both established and entrepreneurial service providers have engaged the Institute to enter or further penetrate the clinical trial marketplace.

Click here to download our Sales Brochure